Stance Capital’s Johnson & Johnson JNJ Stock Holding History

Stance Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,727	Closed	-$3.58M	–	164
2024 Q4	$3.58M	Buy	+24,727	New	+$3.83M	2.22%	24

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stance Capital's JNJ Position: Q1 2025 in Review

Stance Capital sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 24,727 shares — an estimated $3.58M sold.

Stance Capital first reported a position in JNJ in Q4 2024 and held it in 1 quarter. The position peaked at $3.58M in Q4 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Stance Capital reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Stance Capital sold 24,727 Johnson & Johnson shares in Q1 2025, an estimated $3.58M.
Stance Capital first reported a position in Johnson & Johnson in Q4 2024 and held it in 1 quarter.
Stance Capital's Johnson & Johnson position peaked at $3.58M in Q4 2024.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Stance Capital's 13F filing for Q1 2025, filed 16 May 2025.